Skip to main content
Top
Published in: International Urogynecology Journal 1/2009

01-05-2009 | IUGA Female Sexual Dysfunction Roundtable 2008

Evaluation and treatment of female sexual disorders

Authors: Sheryl Kingsberg, Stanley E. Althof

Published in: International Urogynecology Journal | Special Issue 1/2009

Login to get access

Abstract

Prevalence data suggest that more than 40% of women experience sexual problems and that 12% of these women are distressed by the problem. In the 1960s, Masters and Johnson introduced what is now considered the classic linear model of female sexual response based on a physiologic foundation. Recently, Rosemary Basson introduced a nonlinear interconnected model which emphasizes the importance of emotional intimacy and satisfaction as integral components of the female sexual response cycle. According to the Diagnostic and Statistical Manual (DSM-IV TR), there are six female sexual disorders: hypoactive sexual desire disorder, aversion disorder, sexual arousal disorder, female orgasmic disorder, vaginismus, and dyspareunia. Despite the high prevalence, few healthcare professionals take the time or feel adequately trained to assess and treat these sexual problems. Sexuality questionnaires play an integral role in the diagnosis and treatment of male and female sexual dysfunctions. They are used to (1) identify/diagnose individuals with a particular dysfunction, (2) assess the severity of the dysfunction, (3) measure improvement or satisfaction with treatment, (4) examine the impact of the dysfunction on the individual’s quality of life (relationship satisfaction, mood, sexual confidence), and (5) study the impact of the dysfunction on the partner and his or her quality of life. Patient-reported outcomes (PRO) are increasingly important in both clinical practice and research settings. The instruments reviewed have played a significant role in furthering our understanding of the impact of female sexual function on the patient and partner and its treatment. It is important for the clinician and researcher to familiarize themselves with the best available measures for identifying specific dysfunctions, measuring distress due to the sexual dysfunction, assessing treatment efficacy, and objectively evaluating the quality of life issues of women with these dysfunctions. However, even the best PRO cannot replace the clinician–patient interview and the careful gathering of the patient’s sexual history. PROs should always be interpreted and integrated with the woman’s history.
Literature
1.
go back to reference Laumann E, Paik A, Rosen R (1999) Sexual dysfunction in the United States: prevalence and predictors. JAMA 281:537–44PubMedCrossRef Laumann E, Paik A, Rosen R (1999) Sexual dysfunction in the United States: prevalence and predictors. JAMA 281:537–44PubMedCrossRef
2.
go back to reference Bancroft J, Loftus J, Long J (2003) Distress about sex: a national survey of women in heterosexual relationships. Arch Sexual Behavior 32:193–208CrossRef Bancroft J, Loftus J, Long J (2003) Distress about sex: a national survey of women in heterosexual relationships. Arch Sexual Behavior 32:193–208CrossRef
3.
go back to reference Simons J, Carey M (2001) Prevalence of sexual dysfunctions: Results from a decade of research. Arch Sex Behav 30:177–219PubMedCrossRef Simons J, Carey M (2001) Prevalence of sexual dysfunctions: Results from a decade of research. Arch Sex Behav 30:177–219PubMedCrossRef
4.
go back to reference Rosen R (2003) Prevalence and risk factors of sexual dysfunction in men and women. Curr Psychiatry Rep 3:189–95 Rosen R (2003) Prevalence and risk factors of sexual dysfunction in men and women. Curr Psychiatry Rep 3:189–95
5.
go back to reference Kingsberg S (1996) Maintaining and evaluating quality of life after menopause. The Female Patient 21(Supplement):19–24 Kingsberg S (1996) Maintaining and evaluating quality of life after menopause. The Female Patient 21(Supplement):19–24
6.
go back to reference Kingsberg S (2006) Taking a sexual history. Obset Gynecol Clin North Am 6(33):535–47CrossRef Kingsberg S (2006) Taking a sexual history. Obset Gynecol Clin North Am 6(33):535–47CrossRef
7.
go back to reference Kinsey A (1953) Sexual behavior in the human female. Saunders, Philadelphia Kinsey A (1953) Sexual behavior in the human female. Saunders, Philadelphia
8.
go back to reference Masters W, Johnson V (1966) Human sexual response. Little Brown, Boston Masters W, Johnson V (1966) Human sexual response. Little Brown, Boston
9.
go back to reference Kaplan H (1979) Disorders of sexual desire and other new concepts and techniques in sex therapy. Brunner Mazel, New York Kaplan H (1979) Disorders of sexual desire and other new concepts and techniques in sex therapy. Brunner Mazel, New York
10.
go back to reference Leif H (1977) Inhibited sexual desire. Med Aspects Hum Sex 7:94–95 Leif H (1977) Inhibited sexual desire. Med Aspects Hum Sex 7:94–95
11.
go back to reference Basson R (2001) Female sexual response: the role of drugs in the management of sexual dysfunction. Obstet Gynecol 98:350–53PubMedCrossRef Basson R (2001) Female sexual response: the role of drugs in the management of sexual dysfunction. Obstet Gynecol 98:350–53PubMedCrossRef
12.
go back to reference American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington, DC American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington, DC
13.
go back to reference Hayes R, Bennett C, Fairley C, Dennerstein L (2006) What can prevalence studies tell us about female sexual difficulty and dysfunction? J Sex Med 3:589–95PubMedCrossRef Hayes R, Bennett C, Fairley C, Dennerstein L (2006) What can prevalence studies tell us about female sexual difficulty and dysfunction? J Sex Med 3:589–95PubMedCrossRef
14.
go back to reference Segraves R, Woodard T (2006) Female hypoactive sexual desire disorder: history and current status. J Sex Med 3:408–18PubMedCrossRef Segraves R, Woodard T (2006) Female hypoactive sexual desire disorder: history and current status. J Sex Med 3:408–18PubMedCrossRef
15.
go back to reference West S, D’Alosisio A, Agans R, Kalsbeek W, Borisov N, Thorp J (2008) Prevalence of low sexual desire and hypoactive sexual desire disorder in a nationally representative sample of US women. Arch Intern Med 168:1441–49PubMedCrossRef West S, D’Alosisio A, Agans R, Kalsbeek W, Borisov N, Thorp J (2008) Prevalence of low sexual desire and hypoactive sexual desire disorder in a nationally representative sample of US women. Arch Intern Med 168:1441–49PubMedCrossRef
16.
go back to reference Levine S (1992) Sexual life. Plenum, New York Levine S (1992) Sexual life. Plenum, New York
17.
go back to reference Hayes R, Dennerstein (2005) The impact of aging on sexual function and sexual dysfunction in women: a review of population based studies. J Sex Med 2:317–30PubMedCrossRef Hayes R, Dennerstein (2005) The impact of aging on sexual function and sexual dysfunction in women: a review of population based studies. J Sex Med 2:317–30PubMedCrossRef
18.
go back to reference Zumoff B, Strain G, Miller L et al (1995) Twenty-four hour mean plasma testosterone concentration declines with age in normal premenopausal women. J Clin Endocrinol Metabol 80:1429–30CrossRef Zumoff B, Strain G, Miller L et al (1995) Twenty-four hour mean plasma testosterone concentration declines with age in normal premenopausal women. J Clin Endocrinol Metabol 80:1429–30CrossRef
19.
go back to reference Basson R, Berman J, Bennett A et al (2000) Report of the international consensus development conference on female sexual dysfunction: definitions and classifications. J Urol 163:888–93PubMedCrossRef Basson R, Berman J, Bennett A et al (2000) Report of the international consensus development conference on female sexual dysfunction: definitions and classifications. J Urol 163:888–93PubMedCrossRef
20.
go back to reference Basson R, Leiblum S, Brotto L et al (2003) Definitions of women’s sexual dysfunction reconsidered: advocating expansion and revision. J Psychosomatic Obstet Gynecol 24:221–29CrossRef Basson R, Leiblum S, Brotto L et al (2003) Definitions of women’s sexual dysfunction reconsidered: advocating expansion and revision. J Psychosomatic Obstet Gynecol 24:221–29CrossRef
21.
go back to reference Masters W, Johnson V (1970) Human sexual response. Little Brown, Boston Masters W, Johnson V (1970) Human sexual response. Little Brown, Boston
22.
go back to reference Laan E, Everard W, Both S (2005) Female sexual arousal disorder. In: Balon R, Segraves R (eds) Handbook of sexual dysfunction. Marcel Dekker, New York Laan E, Everard W, Both S (2005) Female sexual arousal disorder. In: Balon R, Segraves R (eds) Handbook of sexual dysfunction. Marcel Dekker, New York
23.
go back to reference Meston C, Levin R (2005) Female orgasmic dysfunction. In: Balon R, Segraves R (eds) Handbook of sexual dysfunction. Marcel Dekker, New York Meston C, Levin R (2005) Female orgasmic dysfunction. In: Balon R, Segraves R (eds) Handbook of sexual dysfunction. Marcel Dekker, New York
24.
go back to reference Binik Y, Reissing E, Pukall C, Flory N, Payne K, Khalife S (2002) The female sexual pain disorders: genital pain or sexual dysfunction. Arch Sex Behavior 31:425–29CrossRef Binik Y, Reissing E, Pukall C, Flory N, Payne K, Khalife S (2002) The female sexual pain disorders: genital pain or sexual dysfunction. Arch Sex Behavior 31:425–29CrossRef
25.
go back to reference Lue T, Basson R, Rosen R, Guiliano F, Khoury S, Montorsi F (2004) Sexual medicine. Sexual dysfunction in men and women. 2nd International Consultation on sexual dysfunctions. Health Publications, Paris Lue T, Basson R, Rosen R, Guiliano F, Khoury S, Montorsi F (2004) Sexual medicine. Sexual dysfunction in men and women. 2nd International Consultation on sexual dysfunctions. Health Publications, Paris
26.
go back to reference Kingsberg S, Janata J (2007) Female sexual disorders: assessment, diagnosis and treatment. Urol Clin North Am 34:497–506PubMedCrossRef Kingsberg S, Janata J (2007) Female sexual disorders: assessment, diagnosis and treatment. Urol Clin North Am 34:497–506PubMedCrossRef
27.
go back to reference Tomlinson J (1998) ABC of sexual health: taking a sexual history. Br Med J 317:1573–76 Tomlinson J (1998) ABC of sexual health: taking a sexual history. Br Med J 317:1573–76
28.
go back to reference Basson R (2003) Sexuality and sexual disorder. Clin Updates Women’s Health Care 11:91–94 Basson R (2003) Sexuality and sexual disorder. Clin Updates Women’s Health Care 11:91–94
29.
go back to reference Basson R (2000) Taking the sexual history: part 1: eliciting the sexual concerns of your patient in primary care. Med Aspects Hum Sex 1:13–18 Basson R (2000) Taking the sexual history: part 1: eliciting the sexual concerns of your patient in primary care. Med Aspects Hum Sex 1:13–18
30.
go back to reference Hatzichristou D, Rosen R, Broderick G et al (2004) Clinical evaluation and management strategy for sexual dysfunction in men and women. J Sex Med 1:49–57PubMedCrossRef Hatzichristou D, Rosen R, Broderick G et al (2004) Clinical evaluation and management strategy for sexual dysfunction in men and women. J Sex Med 1:49–57PubMedCrossRef
31.
go back to reference Clayton A (2003) Sexual function and dysfunction in women. Psych Clin North Am 26:673–82CrossRef Clayton A (2003) Sexual function and dysfunction in women. Psych Clin North Am 26:673–82CrossRef
32.
go back to reference Berman J, Berman L, Goldstein I (1999) Female sexual dysfunction: incidence pathophysiology, evaluation and treatment options. Urology 54:381–91CrossRef Berman J, Berman L, Goldstein I (1999) Female sexual dysfunction: incidence pathophysiology, evaluation and treatment options. Urology 54:381–91CrossRef
33.
go back to reference Pauls R, Kleeman S, Karram M (2005) Female sexual dysfunction: principles of diagnosis and therapy. Obstet Gynecol Surv 60:196–205PubMedCrossRef Pauls R, Kleeman S, Karram M (2005) Female sexual dysfunction: principles of diagnosis and therapy. Obstet Gynecol Surv 60:196–205PubMedCrossRef
34.
go back to reference Phillips N (1998) The clinical evaluation of dyspareunia. Int J Impotence Res 10(Suppl 2):117–20 Phillips N (1998) The clinical evaluation of dyspareunia. Int J Impotence Res 10(Suppl 2):117–20
35.
go back to reference Plaut M, Graziottin A, Heaton J (2004) Fast facts: sexual dysfunction. Health Press, Oxford Plaut M, Graziottin A, Heaton J (2004) Fast facts: sexual dysfunction. Health Press, Oxford
36.
go back to reference Althof SE, Symonds T (2007) Patient reported outcomes used in the assessment of premature ejaculation. Urol Clin North Am 34:581–9 viiPubMedCrossRef Althof SE, Symonds T (2007) Patient reported outcomes used in the assessment of premature ejaculation. Urol Clin North Am 34:581–9 viiPubMedCrossRef
37.
go back to reference Rosen RC, Cappelleri JC, Gendrano N III (2002) The International Index of Erectile Function (IIEF): a state-of-the-science review. Int J Impot Res 14:226–44PubMedCrossRef Rosen RC, Cappelleri JC, Gendrano N III (2002) The International Index of Erectile Function (IIEF): a state-of-the-science review. Int J Impot Res 14:226–44PubMedCrossRef
38.
go back to reference Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A (1997) The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 49:822–30PubMedCrossRef Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A (1997) The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 49:822–30PubMedCrossRef
39.
go back to reference US FDA draft guidance for industry (2006) Patient reported outcome measures: use in medical product development to support labeling claims US FDA draft guidance for industry (2006) Patient reported outcome measures: use in medical product development to support labeling claims
40.
go back to reference FDA Guidance Document (2000) Guidance for industry: female sexual dysfunction: clinical development of drug products for treatment FDA Guidance Document (2000) Guidance for industry: female sexual dysfunction: clinical development of drug products for treatment
41.
go back to reference Althof SE, Dean J, Derogatis LR, Rosen RC, Sisson M (2005) Current Perspectives On The Clinical Assessment And Diagnosis Of Female Sexual Dysfunction And Clinical Studies Of Potential Therapies: A Statement Of Concern. J Sex Med 2(Suppl 3):146–53PubMedCrossRef Althof SE, Dean J, Derogatis LR, Rosen RC, Sisson M (2005) Current Perspectives On The Clinical Assessment And Diagnosis Of Female Sexual Dysfunction And Clinical Studies Of Potential Therapies: A Statement Of Concern. J Sex Med 2(Suppl 3):146–53PubMedCrossRef
42.
go back to reference Althof SE, Rosen RC, DeRogatis L, Corty E, Quirk F, Symonds T (2005) Outcome measurement in female sexual dysfunction clinical trials: review and recommendations. J Sex Marital Ther 31:153–66PubMedCrossRef Althof SE, Rosen RC, DeRogatis L, Corty E, Quirk F, Symonds T (2005) Outcome measurement in female sexual dysfunction clinical trials: review and recommendations. J Sex Marital Ther 31:153–66PubMedCrossRef
43.
go back to reference Meston CM (2003) Validation of the Female Sexual Function Index (FSFI) in women with female orgasmic disorder and in women with hypoactive sexual desire disorder. J Sex Marital Ther 29:39–46PubMedCrossRef Meston CM (2003) Validation of the Female Sexual Function Index (FSFI) in women with female orgasmic disorder and in women with hypoactive sexual desire disorder. J Sex Marital Ther 29:39–46PubMedCrossRef
44.
go back to reference Rosen R, Brown C, Heiman J et al (2000) The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 26:191–208PubMedCrossRef Rosen R, Brown C, Heiman J et al (2000) The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 26:191–208PubMedCrossRef
45.
go back to reference Wiegel M, Meston C, Rosen R (2005) The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores. J Sex Marital Ther 31:1–20PubMedCrossRef Wiegel M, Meston C, Rosen R (2005) The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores. J Sex Marital Ther 31:1–20PubMedCrossRef
46.
go back to reference McHorney CA, Rust J, Golombok S et al (2004) Profile of Female Sexual Function: a patient-based, international, psychometric instrument for the assessment of hypoactive sexual desire in oophorectomized women. Menopause 11:474–83PubMedCrossRef McHorney CA, Rust J, Golombok S et al (2004) Profile of Female Sexual Function: a patient-based, international, psychometric instrument for the assessment of hypoactive sexual desire in oophorectomized women. Menopause 11:474–83PubMedCrossRef
47.
go back to reference Rust J, Derogatis L, Rodenberg C, Koochaki P, Schmitt S, Golombok S (2007) Development and validation of a new screening tool for hypoactive sexual desire disorder: The Brief Profile of Female Sexual Function (B-PFSF). Gynecol Endocrinol 23:638–44PubMedCrossRef Rust J, Derogatis L, Rodenberg C, Koochaki P, Schmitt S, Golombok S (2007) Development and validation of a new screening tool for hypoactive sexual desire disorder: The Brief Profile of Female Sexual Function (B-PFSF). Gynecol Endocrinol 23:638–44PubMedCrossRef
48.
go back to reference Clayton AH, Segraves RT, Leiblum S et al (2006) Reliability and validity of the Sexual Interest and Desire Inventory-Female (SIDI-F), a scale designed to measure severity of female hypoactive sexual desire disorder. J Sex Marital Ther 32:115–35PubMedCrossRef Clayton AH, Segraves RT, Leiblum S et al (2006) Reliability and validity of the Sexual Interest and Desire Inventory-Female (SIDI-F), a scale designed to measure severity of female hypoactive sexual desire disorder. J Sex Marital Ther 32:115–35PubMedCrossRef
49.
go back to reference Symonds T, Boolell M, Quirk F (2005) Development of a questionnaire on sexual quality of life in women. J Sex Marital Ther 31:385–97PubMedCrossRef Symonds T, Boolell M, Quirk F (2005) Development of a questionnaire on sexual quality of life in women. J Sex Marital Ther 31:385–97PubMedCrossRef
50.
go back to reference McCoy N (2000) The McCoy Female Sexuality Questionnaire. Qual Life Res 9:739–45CrossRef McCoy N (2000) The McCoy Female Sexuality Questionnaire. Qual Life Res 9:739–45CrossRef
51.
go back to reference Derogatis L, Clayton A, Lewis-D’Agostino D, Wunderlich G, Fu Y (2008) Validation of the female sexual distress scale-revised for assessing distress in women with hypoactive sexual desire disorder. J Sex Med 5:357–64PubMedCrossRef Derogatis L, Clayton A, Lewis-D’Agostino D, Wunderlich G, Fu Y (2008) Validation of the female sexual distress scale-revised for assessing distress in women with hypoactive sexual desire disorder. J Sex Med 5:357–64PubMedCrossRef
Metadata
Title
Evaluation and treatment of female sexual disorders
Authors
Sheryl Kingsberg
Stanley E. Althof
Publication date
01-05-2009
Publisher
Springer-Verlag
Published in
International Urogynecology Journal / Issue Special Issue 1/2009
Print ISSN: 0937-3462
Electronic ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-009-0833-x

Other articles of this Special Issue 1/2009

International Urogynecology Journal 1/2009 Go to the issue

IUGA Female Sexual Dysfunction Roundtable 2008

Assessment of sexual function in women with pelvic floor dysfunction

IUGA Female Sexual Dysfunction Roundtable 2008

IUGA Sexual Dysfunction in Women Roundtable

IUGA Female Sexual Dysfunction Roundtable 2008

Introduction to the 2008 IUGA Sexual Dysfunction in Women Roundtable